BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1453 related articles for article (PubMed ID: 22513401)

  • 1. Intra-tumour heterogeneity: a looking glass for cancer?
    Marusyk A; Almendro V; Polyak K
    Nat Rev Cancer; 2012 Apr; 12(5):323-34. PubMed ID: 22513401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour heterogeneity: principles and practical consequences.
    Stanta G; Jahn SW; Bonin S; Hoefler G
    Virchows Arch; 2016 Oct; 469(4):371-84. PubMed ID: 27412632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis.
    Tellez-Gabriel M; Ory B; Lamoureux F; Heymann MF; Heymann D
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours.
    Khalique L; Ayhan A; Weale ME; Jacobs IJ; Ramus SJ; Gayther SA
    J Pathol; 2007 Feb; 211(3):286-95. PubMed ID: 17154249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour heterogeneity and immune-modulation.
    Jamal-Hanjani M; Thanopoulou E; Peggs KS; Quezada SA; Swanton C
    Curr Opin Pharmacol; 2013 Aug; 13(4):497-503. PubMed ID: 23664091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours.
    Brock A; Chang H; Huang S
    Nat Rev Genet; 2009 May; 10(5):336-42. PubMed ID: 19337290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor genetic heterogeneity].
    Yang YL; Chu JY; Wang MR
    Yi Chuan; 2013 Jan; 35(1):1-9. PubMed ID: 23357259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer intra-tumor heterogeneity.
    Martelotto LG; Ng CK; Piscuoglio S; Weigelt B; Reis-Filho JS
    Breast Cancer Res; 2014 May; 16(3):210. PubMed ID: 25928070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of intratumor heterogeneity: challenges and opportunities.
    Ramón Y Cajal S; Sesé M; Capdevila C; Aasen T; De Mattos-Arruda L; Diaz-Cano SJ; Hernández-Losa J; Castellví J
    J Mol Med (Berl); 2020 Feb; 98(2):161-177. PubMed ID: 31970428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.
    Marusyk A; Tabassum DP; Altrock PM; Almendro V; Michor F; Polyak K
    Nature; 2014 Oct; 514(7520):54-8. PubMed ID: 25079331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-tumor heterogeneity from a cancer stem cell perspective.
    Prasetyanti PR; Medema JP
    Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression.
    Lüönd F; Tiede S; Christofori G
    Br J Cancer; 2021 Jul; 125(2):164-175. PubMed ID: 33824479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer heterogeneity--a multifaceted view.
    De Sousa E Melo F; Vermeulen L; Fessler E; Medema JP
    EMBO Rep; 2013 Aug; 14(8):686-95. PubMed ID: 23846313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor heterogeneity: causes and consequences.
    Marusyk A; Polyak K
    Biochim Biophys Acta; 2010 Jan; 1805(1):105-17. PubMed ID: 19931353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.
    Hu J; Yuan IJ; Mirshahidi S; Simental A; Lee SC; Yuan X
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. epihet for intra-tumoral epigenetic heterogeneity analysis and visualization.
    Chen X; Ashoor H; Musich R; Wang J; Zhang M; Zhang C; Lu M; Li S
    Sci Rep; 2021 Jan; 11(1):376. PubMed ID: 33432081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.